166 related articles for article (PubMed ID: 34772578)
1. Therapeutic potential of targeting cathepsin S in pulmonary fibrosis.
Yoo Y; Choi E; Kim Y; Cha Y; Um E; Kim Y; Kim Y; Lee YS
Biomed Pharmacother; 2022 Jan; 145():112245. PubMed ID: 34772578
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics.
Brown R; Nath S; Lora A; Samaha G; Elgamal Z; Kaiser R; Taggart C; Weldon S; Geraghty P
Respir Res; 2020 May; 21(1):111. PubMed ID: 32398133
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin S (CTSS) activity in health and disease - A treasure trove of untapped clinical potential.
Smyth P; Sasiwachirangkul J; Williams R; Scott CJ
Mol Aspects Med; 2022 Dec; 88():101106. PubMed ID: 35868042
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin S: therapeutic, diagnostic, and prognostic potential.
Wilkinson RD; Williams R; Scott CJ; Burden RE
Biol Chem; 2015 Aug; 396(8):867-82. PubMed ID: 25872877
[TBL] [Abstract][Full Text] [Related]
5. miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production.
Weldon S; McNally P; McAuley DF; Oglesby IK; Wohlford-Lenane CL; Bartlett JA; Scott CJ; McElvaney NG; Greene CM; McCray PB; Taggart CC
Am J Respir Crit Care Med; 2014 Jul; 190(2):165-74. PubMed ID: 24940638
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal cysteine protease cathepsin S is involved in cancer cell motility by regulating store-operated Ca
Lin HH; Chen SJ; Shen MR; Huang YT; Hsieh HP; Lin SY; Lin CC; Chang WW; Chang JY
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118517. PubMed ID: 31340164
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation.
Taleb S; Cancello R; Clément K; Lacasa D
Endocrinology; 2006 Oct; 147(10):4950-9. PubMed ID: 16825321
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin S regulates renal fibrosis in mouse models of mild and severe hydronephrosis.
Yao X; Cheng F; Yu W; Rao T; Li W; Zhao S; Zhou X; Ning J
Mol Med Rep; 2019 Jul; 20(1):141-150. PubMed ID: 31115520
[TBL] [Abstract][Full Text] [Related]
9. Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy.
De Pasquale V; Moles A; Pavone LM
Cells; 2020 Apr; 9(4):. PubMed ID: 32326609
[TBL] [Abstract][Full Text] [Related]
10. Identification of putative cathepsin S in mangrove red snapper Lutjanus argentimaculatus and its role in antigen presentation.
Zhou J; Li L; Cai ZH
Dev Comp Immunol; 2012 May; 37(1):28-38. PubMed ID: 22210546
[TBL] [Abstract][Full Text] [Related]
11. Symbiotic gut commensal bacteria act as host cathepsin S activity regulators.
Steimle A; Gronbach K; Beifuss B; Schäfer A; Harmening R; Bender A; Maerz JK; Lange A; Michaelis L; Maurer A; Menz S; McCoy K; Autenrieth IB; Kalbacher H; Frick JS
J Autoimmun; 2016 Dec; 75():82-95. PubMed ID: 27484364
[TBL] [Abstract][Full Text] [Related]
12. Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages.
Hughes CS; Colhoun LM; Bains BK; Kilgour JD; Burden RE; Burrows JF; Lavelle EC; Gilmore BF; Scott CJ
Part Fibre Toxicol; 2016 Apr; 13():19. PubMed ID: 27108091
[TBL] [Abstract][Full Text] [Related]
13. Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy.
Chen SJ; Chen LH; Yeh YM; Lin CK; Lin PC; Huang HW; Shen MR; Lin BW; Lee JC; Lee CC; Lee YF; Chiang HC; Chang JY
Theranostics; 2021; 11(10):4672-4687. PubMed ID: 33754020
[No Abstract] [Full Text] [Related]
14. Cysteine cathepsins and extracellular matrix degradation.
Fonović M; Turk B
Biochim Biophys Acta; 2014 Aug; 1840(8):2560-70. PubMed ID: 24680817
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-Derived Cathepsin S Remodels the Extracellular Matrix to Promote Liver Fibrogenesis.
Zuo T; Xie Q; Liu J; Yang J; Shi J; Kong D; Wang Y; Zhang Z; Gao H; Zeng DB; Wang X; Tao P; Wei W; Wang J; Li Y; Long Q; Li C; Chang L; Ning H; Li Y; Cui C; Ge X; Wu J; Li G; Hong X; Yang X; Dai E; He F; Wu J; Ruan Y; Lu S; Xu P
Gastroenterology; 2023 Sep; 165(3):746-761.e16. PubMed ID: 37263311
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin S Alters the Expression of Pro-Inflammatory Cytokines and MMP-9, Partially through Protease-Activated Receptor-2, in Human Corneal Epithelial Cells.
Klinngam W; Fu R; Janga SR; Edman MC; Hamm-Alvarez SF
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423938
[TBL] [Abstract][Full Text] [Related]
17. Rational design of humanized antibody inhibitors for cathepsin S.
Yu PW; Kao G; Dai Z; Nasertorabi F; Zhang Y
Arch Biochem Biophys; 2024 Jan; 751():109849. PubMed ID: 38061628
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Inhibition of Cathepsin S Suppresses Abdominal Aortic Aneurysm in Mice.
Lai CH; Chang JY; Wang KC; Lee FT; Wu HL; Cheng TL
Eur J Vasc Endovasc Surg; 2020 Jun; 59(6):990-999. PubMed ID: 32033870
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin S attenuates endosomal EGFR signalling: A mechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors.
Huang CC; Lee CC; Lin HH; Chang JY
Sci Rep; 2016 Jul; 6():29256. PubMed ID: 27387133
[TBL] [Abstract][Full Text] [Related]
20. Sequence and expression analysis of cathepsin S gene in the miiuy croaker Miichthys miiuy.
Sun YN; Xu TJ; Wang JX; Cheng YZ; Wang RX
Fish Physiol Biochem; 2011 Dec; 37(4):761-5. PubMed ID: 21424529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
